Switch to:
More From Other Websites
Theravance Biopharma Enrolls First Patient in Phase 3 Registrational Study of Telavancin in... Mar 04 2015
Orexigen Soars as Interim Data on Contrave Comes to Light - Analyst Blog Mar 04 2015
Oncolytics' Reolysin Gets Orphan Drug Status Yet Again - Analyst Blog Mar 04 2015
Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog Mar 04 2015
Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog Mar 03 2015
Backed by Genentech alum Dave Goeddel, this company looks like the next biotech IPO Mar 02 2015
Amgen's Kyprolis Fares Better than Velcade in Study - Analyst Blog Mar 02 2015
Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog Mar 02 2015
Isis Pharmaceuticals Up on Q4 Earnings and Revenues Beat - Analyst Blog Mar 02 2015
BioMarin's Q4 Loss Narrower than Expected, Gives 2015 View - Analyst Blog Feb 26 2015
Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog Feb 26 2015
Lightning Round: This group goes higher tomorrow Feb 25 2015
Theravance to Present at the Cowen Healthcare Conference Feb 25 2015
Iridian exits position in Wyndham Worldwide Corporation Feb 25 2015
Why Theravance (THRX) Could Be Positioned for a Surge? - Tale of the Tape Feb 25 2015
Eli Lilly's BIL Filing Delayed, Baricitinib Scores in Phase III - Analyst Blog Feb 24 2015
THERAVANCE INC Files SEC form 8-K, Other Events Feb 23 2015
Theravance, Inc. Announces Cash Dividend of $0.25 per Share Payable to Stockholders of Record as of... Feb 23 2015
Iridian boosts its holdings in W.R. Grace and Company by 25% Feb 20 2015
Iridian increases its stake in Theravance Feb 19 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK